Cubist Pharmaceuticals Appoints Alison Lawton to Board of Directors

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the appointment of Alison Lawton to its Board of Directors. Ms. Lawton is currently Senior Vice President, General Manager Biosurgery, at Genzyme Corporation (now part of Sanofi). With the addition of Ms. Lawton, the Cubist Board of Directors consists of 10 members, nine of whom are independent. “Alison’s tremendous breadth and depth of experience in international regulatory affairs and operations adds

Feed Date: 
February 16, 2012